Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Müller J, Krijgsman O, Tsoi J, Robert L, Hugo W, Song C, Kong X, Possik PA, Cornelissen-Steijger PD, Geukes Foppen MH, Kemper K, Goding CR, McDermott U, Blank C, Haanen J, Graeber TG, Ribas A, Lo RS, Peeper DS.
Müller J, et al.
Nat Commun. 2014 Dec 15;5:5712. doi: 10.1038/ncomms6712.
Nat Commun. 2014.
PMID: 25502142
Free PMC article.